- ￥600 - 3200
- 上海莼试
- CS-01Y74816
- 国产
- 2025年07月06日
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
55
- 英文名：
Doxapram hydrochloride hydrate
- CAS号：
7081-53-0
- 供应商：
上海莼试
- 保存条件：
Store at -20°C
- 规格：
10mM (in 1mL DMSO) 50mg
分子式:
分子量:432.98
溶解度:≥ 20.05mg/mL in DMSO with gentle warming
储存条件:Store at -20°C
General tips:For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition:Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
Doxapram hydrochloride hydrate inhibits TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric channel function with EC50 of 410 nM, 37 μM, 9 μM, respectively.Target: Potassium ChannelDoxapram is a respiratory stimulant. Doxapram (15-150 microM) also evoked 3H overflow in a concentration dependent manner, and doxapram-evoked release was inhibited by the Ca2+ channel blocker nifedipine (5 microM). Analysis of released tritiated compounds suggested that doxapram preferentially stimulated the release of dopamine. Our results indicate that the mechanism of action of doxapram shares similarities with that of hypoxia in the carotid body [1]. Doxapram (1-100 microM) caused rapid, reversible and dose-dependent inhibitions of K+ currents recorded in type I cells (IC50 approximately 13 microM). doxapram was also seen to directly inhibit Ca(2+)-independent K+ currents. Doxapram was a more potent inhibitor of the Ca(2+)-activated K+ currents recorded under control conditions. Doxapram (10 microM) was without effect on L-type Ca2+ channel currents recorded under conditions where K+ channel activity was minimized and was also without significant effect on K+ currents recorded in the neuronal cell line NG-108 15, suggesting a selective effect on carotid body type I cells. The effects of doxapram on type I cells show similarities to those of the physiological stimuli of the carotid body, suggesting that doxapram may share a similar mechanism of action in stimulating the intact organ [2].
商品属性：
| 货号 | CS-01Y74816 | 规格 | 10mM (in 1mL DMSO) 50mg |
| CAS号 | 7081-53-0 | 分子量 | 432.98 |
| 含量 | >99.00% | 别名 | N/A |
| 分子式 | 化学名 | 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydrate;hydrochloride | |
| 产地 | 国产 | 用途 | 仅供科研研究实验 |
抗逆滴加序列
每次向板内滴加抗原时，移液器滴头要与平面45度悬空，不要触碰到孔内的液体，由后向前依次滴加(即浓度由低往高滴加)。
抗感染反应期
抗原抗体在室温20~25℃下，必须反应30min以上，若环境温度低于室温，可将微量反应板置于恒温培养箱中，使二者充分反应。
旅游温度
磷酸盐缓冲液的pH值要在高压灭菌后进行滴定，往往在高压后pH值会有所改变，所以高压后再调一次pH值更为准确。磷酸盐缓冲液一经使用保存期不要超过3周。当pH<5.8时，红细胞会产生自凝现象;当pH>7.8时，图形洗脱加快，易造成肉眼观察产生误差;p H=7.2时，红细胞沉降最充分，图形最清晰。
当滴注 1%红细胞悬液时，应经常摇晃红细胞悬液，使红细胞均匀地分布在磷酸缓冲液中，以防止红细胞下降。
反应时间及温度
加入鸡红血球之后，反应板在室温(20~25℃)静置30~40min，对照孔血球下沉于孔底，即可判定结果。若室温达不到实验要求，需相应调整反应时间。当环境温度低于4℃时，红细胞发生自凝;高于37℃时，会发生反应物分离和红细胞溶血。
公司正在出售的产品：
| Recombnant Human TLR7 proten | NSP3 Antibody Blocking Peptide |
| Recombinant Human Nmnat1 | Recombinant Human XPO1, N-His |
| CAGE1 Antibody Blocking Peptide | Recombinant Salmnella typhimurium murE protein,N-His Tag |
| Collagen V Antibody Blocking Peptide | Recombinant Human FN1, N-His |
| LRCH1 Antibody Blocking Peptide | Recombinant Human DLD protein |
| H2AFJ Antibody Blocking Peptide | Recombinant Human AMIGO2 protein |
| HSP-20 Antibody Blocking Peptide | Recombinant Human IL21, C-His |
| Ube2L6 Antibody Blocking Peptide | 1号染色体开放阅读框105封闭多肽 |
| phospho-ALK (Tyr1586) Antibody Blocking Peptide | Recombinant Mouse FCRL1/FcRH1 protein ,C- His Tag |
| Recombinant mouse SLC10A2 protein, N-Sumo | Recombinant Hiush blueberry O-methyltransferase protein,N and C-His Tag |
| E.coli DH-5 Alpha Bacterial protein | Recombinant Human H2AFJ protein |
| HTR2A Antibody Blocking Peptide | Recombinant Tomato WRKY domain-containing protein protein ,N-His Tag |
| Isoniazid-KLH | Doxapram hydrochloride hydrateRecombinant Human FGF16 protein,No Tag |
| Phospho-MYPT1 (Thr696) Antibody Blocking Peptide | Recombinant Human PTH1R protein |
| SPAG8 Antibody Blocking Peptide | Recombinant Human NPES/PSA, N-His |
1.本蛋白酶抑制剂混合物为100×的储存液，使用时按照1:100的比例加入到裂解液中(例如，1ml裂解液中加入10μl蛋白酶抑制剂混合物)，混匀后即可使用。根据需要，0.5M的EDTA也按照1:100的比例加入到裂解液中（如用于检测金属蛋白酶活性，则不宜添加EDTA）。含有蛋白酶抑制剂混合物的裂解液宜现用现配，不宜配制后冻存待后续使用。
2. 待所需的抑制剂添加完毕混匀后，就可以开始进行哺乳动物组织的裂解和蛋白提取。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Synthesis of Peptidomimetic Conjugates of Cyclic Nucleoside Phosphonates
ester hydrochloride (Aldrich) Ethan‐1,2‐diol (ethylene glycol) 1‐Hydroxybenzotriazole hydrate (HOBt; Aldrich
acedapsone beclomethasone acenocumarol bemegride acetarsol benactyzine hydrochloride acetazolamide bendroflumethiazide acetylcholine
; distilled over CaH 2 ) Propargylamine N ‐Hydroxybenzotriazole hydrate (HOBt
技术资料暂无技术资料 索取技术资料
